D. Smith

发表

Results of a Nationwide Veterans Administration Cooperative Study Comparing the Efficacy and Toxicity of Carbamazepine, Phenobarbital, Phenytoin, and Primidone

J. Cramer, R. Mattson, R. Novelly, 1987, Epilepsia.

Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association.

N L Greengold, D B Smith, J F Toole, 1999, JAMA.

Pseudoseizures

L. C. Ward, D. King, B. Gallagher, 1982, Neurology.

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).

E. Newlands, M. Stevens, G. Rustin, 1992, British Journal of Cancer.

Increasing and planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) by adding recombinant human methionyl granulocyte colony-stimulating factor (G-CSF; filgrastim) in the treatment of small cell lung cancer (SCLC). Medical Research Council Lung Cancer Working Party.

D. Machin, D. Girling, R. Stephens, 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).

Wednesday July 5, 2006 13:30–15:00 Poster Session 3 Epilepsy Syndromes

E. Ben-Menachem, L. Gjerstad, M. Brodie, 2006 .

Partially Successful Treatment of Rasmussen's Encephalitis with Zidovudine: Symptomatic Improvement Followed by Involvement of the Contralateral Hemisphere

D. Smith, Dennis B. Smith, J. Detoledo, 1994, Epilepsia.

EMOP/CA chemotherapy for the treatment of aggressive non-Hodgkin's lymphomas.

E. Newlands, E. Boesen, G. Rustin, 1989, European journal of cancer & clinical oncology.

Multicenter long‐term safety and efficacy study of vigabatrin for refractory complex partial seizures

R. Mattson, E. Ben-Menachem, B. Wilder, 1991, Neurology.

Cerebral amyloid angiopathy presenting as transient ischemic attacks. Case report.

D. Smith, P. Philpott, M. Hitchcock, 1985, Journal of neurosurgery.

Interaction of Phenytoin and Folate in the Rat

D. Smith, G. F. Carl, D. Smith, 1983, Epilepsia.

Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy

E. Newlands, G. Rustin, K. Bagshawe, 1991, The Lancet.

Comparison of intravenous ketorolac and alfentanil as supplements to propofol anesthesia for diagnostic panendoscopy.

D. Klotch, D. Smith, M. Ridley, 1995, Journal of clinical anesthesia.

Myoclonus with electrocerebral silence in a patient receiving penicillin.

J. Sackellares, D. Smith, 1979, Archives of neurology.

Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.

R. Johnston, J. Wagstaff, D. Smith, 1987, Cancer treatment reports.

Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy.

E. Newlands, G. Rustin, K. Bagshawe, 1990, British Journal of Cancer.

A phase I/II study of the 5-HT3 antagonist GR38032F in the anti-emetic prophylaxis of patients receiving high-dose cisplatin chemotherapy

S. M. Crawford, E. Newlands, K. Bagshawe, 2004, Cancer Chemotherapy and Pharmacology.

Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non‐small cell lung cancer. From the Manchester Lung Tumour Group

J. Barclay, N. Thatcher, D. Smith, 1988, Cancer.

Toward an optimal "antiplatelet" dose of aspirin: Preliminary observations.

C. Filley, D. Smith, J. Hormes, 1991, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Current approaches to diagnosis and treatment of gestational trophoblastic disease

D. Smith, S. O’Reilly, E. Newlands, 1993, Current opinion in obstetrics & gynecology.

Three months treatment with chemotherapy and radiotherapy for small cell lung cancer.

N. Thatcher, D. Smith, R. Stout, 1985, British Journal of Cancer.

Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study

P. Clark, D. Smith, H. Innes, 2003, British Journal of Cancer.

The effect of chronic phenytoin treatment on tissue folate concentrations and on the activities of the methyl synthetic enzymes in the rat.

D. Smith, G. F. Carl, 1983, The Journal of nutrition.

VAD chemotherapy—toxicity and efficacy—in patients with multiple myeloma and other lymphoid malignancies

J. Chang, D. Crowther, R. Swindell, 1987, Hematological oncology.

Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis.

E. Newlands, G. Rustin, K. Bagshawe, 1989, British Journal of Cancer.

Optimum management of pineal germ cell tumours.

E. Newlands, G. Rustin, K. Bagshawe, 1991, Clinical oncology (Royal College of Radiologists (Great Britain)).

Single agent activity of methotrexate in advanced non-seminomatous testicular germ cell tumours.

G. Rustin, D. Smith, R. Hitchins, 1988, European journal of cancer & clinical oncology.

Efficacy and safety of zonisamide: results of a multicenter study

J. Sackellares, R. Lesser, L. Lamoreaux, 1993, Epilepsy Research.

Don't ignore a positive pregnancy test.

G. Rustin, D. Smith, K. Bagshawe, 1988, BMJ.

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures.

J. Cramer, R. Mattson, J. McNamara, 1985, The New England journal of medicine.

Combination chemotherapy for primitive neuroectodermal and other malignant brain tumours.

A. Barrett, M. Gaze, D. Smith, 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).

Demyelinating disease presenting as Wallenberg's syndrome. Report of a patient.

D. Smith, B. DeMasters, 1981, Stroke.

Computer system for assisting with clinical interpretation of tumour marker data.

S Gallivan, E S Newlands, M S Leaning, 1992, BMJ.

Multiple myeloma involving the jaws

D. Smith, 1957 .

Non‐secretory multiple myeloma: A report of 13 cases with a review of the literature

J. Chang, D. Smith, J. Howard Scarffe, 1986, Hematological oncology.

Scleroderma; its oral manifestations.

D. Smith, 1958, Oral surgery, oral medicine, and oral pathology.

A multicentre study of vigabatrin for drug-resistant epilepsy.

R. Mattson, E. Ben-Menachem, B. Wilder, 1989, British journal of clinical pharmacology.

Interactions between folates and carbamazepine or valproate in the rat

D. Smith, G. F. Carl, D. B. Smith, 1982, Neurology.

Vigabatrin for refractory complex partial seizures

R. Mattson, E. Ben-Menachem, B. Wilder, 1987, Neurology.

Ketorolac or fentanyl to supplement local anesthesia?

D. Smith, V. Bosek, C. Cox, 1992, Journal of clinical anesthesia.

Protein C deficiency: a cause of amaurosis fugax?

D. Smith, G. Ens, D. B. Smith, 1987, Journal of neurology, neurosurgery, and psychiatry.

Sneddon's disease presenting with visual loss and dementia.

W. Wilson, D. Smith, C. Seibert, 1988, Journal of clinical neuro-ophthalmology.

Headache with neurological deficits and CSF lymphocytosis: A transient ischemic attack mimic.

A. Norbash, G. Albers, M. Lansberg, 1999, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Effect of chronic phenobarbital treatment on folates and one-carbon enzymes in the rat.

D. Smith, G. F. Carl, 1984, Biochemical pharmacology.

Pre-clinical studies of a novel anti-mitotic agent, amphethinile.

D. Smith, A. McGown, B. Fox, 1988, British Journal of Cancer.

Ifosfamide by bolus as treatment for advanced non-small cell lung cancer

N. Thatcher, W. Steward, D. Smith, 2004, Cancer Chemotherapy and Pharmacology.

A phase II study of oral weekly 4-demethoxydaunorubicin in advanced breast cancer.

A. Howell, D. Smith, D. B. Smith, 1987, European journal of cancer & clinical oncology.

Folate metabolism and the anticonvulsant efficacy of phenobarbital.

L. Racusen, D. Smith, 1973, Archives of neurology.

Single agent activity of carboplatin in patients with previously untreated non-seminomatous germ cell tumours.

E. Newlands, G. Rustin, D. Smith, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Dialysis encephalopathy in peritoneal dialysis.

J. Lewis, D. Smith, A. Alfrey, 1980, JAMA.

Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial*

J. Kremer, L. Moreland, P. Mease, 2005, Current medical research and opinion.

Dose intensification in the treatment of patients with testicular germ cell tumours.

G. Rustin, D. Smith, S. O’Reilly, 1994, European journal of cancer.

Infiltrating lobular carcinoma of the breast: response to endocrine therapy and survival.

A. Howell, J. Wagstaff, D. Smith, 1987, European journal of cancer & clinical oncology.

Lumbar pain in stage 1 testicular germ cell tumours: a symptom preceding radiological abnormality.

E. Newlands, G. Rustin, K. Bagshawe, 1989, British journal of urology.

Ischemic optic neuropathy decompression trial.

D. Smith, 1995, JAMA.

Estimating the economic burden of gastric cancer in the United States.

K. Knopf, J. Munakata, D. Smith, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A weekly alternating chemotherapy regimen with low toxicity for the treatment of aggressive lymphoma

E. Newlands, C. Brock, M. Bower, 1996, Cancer Chemotherapy and Pharmacology.

Does neuroretinitis rule out multiple sclerosis?

W. Wilson, D. Smith, 1989, Archives of neurology.